Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KASTRUP TANDKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.0% 2.4% 1.4% 1.6% 0.9% 1.3% 11.5% 11.3%   Credit score (0-100)   70 65 78 74 88 78 21 21   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   0.2 0.0 12.6 3.4 145.3 18.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,578 1,232 1,439 1,319 1,871 1,429 0.0 0.0   EBITDA   22.0 -227 135 29.0 278 62.3 0.0 0.0   EBIT   -9.3 -250 114 4.3 248 18.6 0.0 0.0   Pre-tax profit (PTP)   -8.5 -259.4 127.3 -40.5 217.9 2.0 0.0 0.0   Net earnings   -8.1 -204.0 99.3 -27.4 164.1 -1.0 0.0 0.0   Pre-tax profit without non-rec. items   -8.5 -259 127 -40.5 218 2.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   50.4 27.2 30.3 129 99.9 268 0.0 0.0   Shareholders equity total   1,239 981 1,025 941 1,048 988 802 802   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,654 1,519 1,593 1,408 1,854 1,644 802 802   Net Debt   -1,225 -964 -1,023 -866 -1,411 -1,006 -802 -802     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,578 1,232 1,439 1,319 1,871 1,429 0.0 0.0   Gross profit growth   -11.2% -21.9% 16.8% -8.3% 41.8% -23.6% -100.0% 0.0%   Employees   2 3 3 3 3 3 0 0   Employee growth %   0.0% 50.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,654 1,519 1,593 1,408 1,854 1,644 802 802   Balance sheet change%   -8.6% -8.2% 4.9% -11.6% 31.7% -11.3% -51.2% 0.0%   Added value   22.0 -226.9 135.1 29.0 272.9 62.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -63 -46 -18 74 -59 124 -268 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -0.6% -20.3% 7.9% 0.3% 13.3% 1.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -0.0% -15.8% 9.0% 0.3% 15.6% 2.6% 0.0% 0.0%   ROI %   -0.0% -22.5% 14.0% 0.4% 25.6% 4.4% 0.0% 0.0%   ROE %   -0.6% -18.4% 9.9% -2.8% 16.5% -0.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   76.1% 65.6% 65.3% 66.9% 56.6% 60.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -5,562.1% 424.8% -757.5% -2,986.1% -508.2% -1,614.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   3.6 2.5 2.5 2.3 2.0 1.9 0.0 0.0   Current Ratio   3.8 2.7 2.7 2.7 2.2 2.1 0.0 0.0   Cash and cash equivalent   1,224.6 963.8 1,023.4 866.5 1,411.4 1,005.7 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   890.3 655.8 670.5 517.5 647.9 395.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   11 -76 45 10 91 21 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   11 -76 45 10 93 21 0 0   EBIT / employee   -5 -83 38 1 83 6 0 0   Net earnings / employee   -4 -68 33 -9 55 -0 0 0